Jeffrey L. Wade

2023

In 2023, Jeffrey L. Wade earned a total compensation of $2M as President and Chief Financial Officer at Lexicon Pharmaceuticals, a 1% decrease compared to previous year.

Compensation breakdown

Bonus$200,097
Option Awards$852,786
Salary$535,729
Stock Awards$358,036
Other$16,220
Total$1,962,868

Wade received $852.8K in option awards, accounting for 43% of the total pay in 2023.

Wade also received $200.1K in bonus, $535.7K in salary, $358K in stock awards and $16.2K in other compensation.

Rankings

In 2023, Jeffrey L. Wade's compensation ranked 542nd out of 2,978 executives tracked by ExecPay. In other words, Wade earned more than 81.8% of executives.

ClassificationRankingPercentile
All
542
out of 2,978
82nd
Division
Manufacturing
311
out of 1,637
81st
Major group
Chemicals And Allied Products
216
out of 906
76th
Industry group
Drugs
213
out of 869
76th
Industry
Pharmaceutical Preparations
133
out of 627
79th

Pay ratio

Jeffrey L. Wade's Pay$1,962,868
Median Employee's Pay$206,303
Pay Ratio

10

to 1

In 2023, the annual total compensation of Jeffrey L. Wade was $1,962,868.

The annual total compensation of the median employee at Lexicon Pharmaceuticals was $206,303.

The ratio of Jeffrey L. Wade's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on March 26, 2024.

Wade's colleagues

We found four more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2023.

2023

Lonnel Coats

Lexicon Pharmaceuticals

Chief Executive Officer

2023

Craig Granowitz

Lexicon Pharmaceuticals

Chief Medical Officer

2023

Brian Crum

Lexicon Pharmaceuticals

General Counsel

2023

Alan Main

Lexicon Pharmaceuticals

Executive Vice President, Innovation and Chemical Sciences

News

You may also like